Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?

doi:10.4254/wjh.v15.i12.1284

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4067)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

2159

Figures (1-1)

274

Tables (1-2)

267

Sum=2816

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

138

Download

495

Sum=633

Publishing Process of This Article

Item

Count

Browse

118

Download

390

Sum=508

Dec 27, 2023 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Dec 27, 2023; 15(12): 1284-1293
Published online Dec 27, 2023. doi: 10.4254/wjh.v15.i12.1284

Full Size Figure Download Figure

Figure 1 Simplified algorithm for therapies in managing advanced-stage intrahepatic cholangiocarcinoma. iCCA: Intrahepatic cholangiocarcinoma; TAE: Trans-arterial embolization; TACE: Trans-arterial chemoembolization; TARE: Transarterial radioembolization; FGFR: Fibroblast Growth Factor Receptor FOLFOX: FOL: Folinic acid (leucovorin), F: Fluorouracil (5-FU), OX: Oxaliplatin; IDH: Isocitrate Dehydrogenase; CT: Computed tomography; CT-HDRBT: CT-guided high-dose-rate interstitial brachytherapy.

Citation: Elvevi A, Laffusa A, Elisei F, Morzenti S, Guerra L, Rovere A, Invernizzi P, Massironi S. Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? World J Hepatol 2023; 15(12): 1284-1293
URL: https://www.wjgnet.com/1948-5182/full/v15/i12/1284.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i12.1284